Women's Health
Daniel Grossman, MD; Sarah Raifman, MSc; Natalie Morris, MPH; et al.
open access
has audio
JAMA Intern Med. 2024;184(8):873-881. doi:10.1001/jamainternmed.2024.1476
This cohort study estimates the effectiveness, acceptability, and feasibility of dispensing mifepristone for medication abortion using a mail-order pharmacy.
-
Audio:
Mail-Order Pharmacy Dispensing of Mifepristone for Abortion After In-Person Screening
Priti Bandi, PhD; Jessica Star, MA, MPH; Kilan Ashad-Bishop, PhD; et al.
has audio
JAMA Intern Med. 2024;184(8):882-891. doi:10.1001/jamainternmed.2024.1655
This cross-sectional study investigates the prevalence of up-to-date lung cancer screening across the 50 US states and the District of Columbia in 2022.
-
Audio:
Lung Cancer Screening in the US, 2022
Travis P. Baggett, MD, MPH; Nora Sporn, MA, MPH; Joana Barbosa Teixeira, MA; et al.
JAMA Intern Med. 2024;184(8):892-902. doi:10.1001/jamainternmed.2024.1662
This randomized clinical trial examines whether patient navigation improves lung cancer screening completion among people experiencing homelessness.
Zhuoer Lin, PhD; Justin Ye, BA; Heather Allore, PhD; et al.
JAMA Intern Med. 2024;184(8):904-914. doi:10.1001/jamainternmed.2024.1132
This cross-sectional study assesses how racial differences in early life, particularly educational circumstances, are collectively and individually associated with racial disparities in late-life cognition among older adults in the US.
-
Editorial
Early-Life Education Quality and Quantity
Raegan W. Durant, MD, MPH
JAMA Intern Med
Anna Tuisku, PhD; Mikko Rahkola, MD; Pentti Nieminen, PhD; et al.
JAMA Intern Med. 2024;184(8):915-921. doi:10.1001/jamainternmed.2024.1822
This randomized clinical trial examines the relative effectiveness of electronic cigarettes in smoking cessation.
Nancy A. Rigotti, MD; Neal L. Benowitz, MD; Judith J. Prochaska, PhD, MPH; et al.
open access
JAMA Intern Med. 2024;184(8):922-930. doi:10.1001/jamainternmed.2024.1313
This randomized clinical trial seeks to determine the efficacy and safety of cytisinicline vs placebo to produce abstinence from e-cigarette use in adults seeking to quit vaping nicotine.
Sara Y. Tartof, PhD, MPH; Jeff M. Slezak, MS; Timothy B. Frankland, MA; et al.
open access
JAMA Intern Med. 2024;184(8):932-940. doi:10.1001/jamainternmed.2024.1640
This case-control study estimates the association between receipt of the BNT162b2 XBB vaccine and medically attended COVID-19 outcomes among US adults 18 years and older.
Jessie Torgersen, MD, MHS, MSCE; Alyssa K. Mezochow, MD; Craig W. Newcomb, MS; et al.
open access
JAMA Intern Med. 2024;184(8):943-952. doi:10.1001/jamainternmed.2024.1836
This cohort study identifies the most potentially hepatotoxic medications based on clinical incidence rates of hospitalizations for severe acute liver injury (ALI) and examines how these rates compare with the hepatotoxicity categorization of severe ALI using published case reports.
Christopher M. Jones, PharmD, DrPH; Carla Shoff, PhD; Carlos Blanco, MD, PhD; et al.
JAMA Intern Med. 2024;184(8):954-962. doi:10.1001/jamainternmed.2024.1733
This cohort study evaluates access to medications for opioid use disorder (MOUD), naloxone, and behavioral health care and their association with decreased fatal overdose risk among Medicare beneficiaries with recent nonfatal overdose experience.
Timothy S. Anderson, MD, MAS; Linnea M. Wilson, MPH; Jeremy B. Sussman, MD, MS
JAMA Intern Med. 2024;184(8):963-970. doi:10.1001/jamainternmed.2024.1302
This cross-sectional study compares 10-year atherosclerotic cardiovascular disease risk and recommendations for primary prevention statin therapy between the 2023 American Heart Association (AHA) Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations and the 2013 AHA/American College of Cardiology pooled cohort equations.